Nucleic Acid BCT is now available in a 10 mL configuration!
Stabilization
Maximize your laboratory efficiency.
With our patented portfolio of stabilization solutions, you can ship and store samples at room temperature, mitigating pre-analytical variation in critical samples, easing handling concerns and allowing for batch processing.


Cell-Free DNA BCT®
A direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA…

Cell-Free DNA BCT® RUO
Cell-Free DNA BCT® CE
A blood collection tube that stabilizes cell-free DNA for up to 14 days at 6 °C to 37 °C* and CTCs for up to 7 days at 15 °C to 30 °C*. It is available…

Nucleic Acid BCT™
A direct draw venous whole blood collection device that maintains draw-time concentrations of cell-free DNA, cell-free RNA and extracellular vesicles for up to 7 days when…

Protein Plus BCT™
A direct draw whole blood collection tube intended for the stabilization of draw-time concentrations of plasma proteins for up to 5 days* at ambient temperature…

Cyto-Chex® BCT
A direct draw blood collection tube that maintains cellular morphology and surface antigen expression, including cluster of differentiation (CD) markers, prior to…
RNA Complete BCT®
A blood collection tube that maintains the draw time concentration of cell-free RNA and extracellular vesicles, such as exosomes, for up to 7 days at room temperature…
Streck Cell Preservative®
An easy-to-use liquid preservative that maintains white blood cell integrity and allows CD markers to be measured through flow cytometric…

Streck® Urine Preserve
A ready-to-use liquid reagent that stabilizes nucleic acid targets in urine for up to 7 days at 6 °C to 37 °C to limit changes associated with sample handling, shipping…

NEAT Liquid Biopsy Kit – Streck BCT
Formulated to capture, concentrate and extract cfDNA from plasma samples isolated from Streck blood collection tubes. It is optimized for automated…
The latest from the blog


FDA clearance brings liquid biopsy into a new era
